Hypophosphatemic Osteomalacia Due to Drug-induced Fanconi's Syndrome Associated with Adefovir Dipivoxil Treatment for Hepatitis B
Authors:
Open Access
- 1 January 2014
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 53 (3) , 233-237
Abstract
We herein present the case of a 58-year-old Japanese man with Fanconi's syndrome with a 13-month history of bone pain in his ribs, hips, knees and ankles. He had been receiving low-dose adefovir dipivoxil (ADV) for the treatment of lamivudine-resistant chronic hepatitis B virus infection for eight years and subsequently developed severe hypophosphatemia and proximal renal tubule dysfunction. Magnetic resonance imaging showed multiple insufficiency fractures in the ribs, ileum, tibia and calcaneus. Whole-body bone scintigraphy demonstrated increased uptake in those areas. Following dose reduction of ADV and the administration of treatment with calcitriol and phosphates, the patient's serum phosphate level increased and his clinical symptoms improved. Physicians prescribing ADV should carefully monitor the renal function and serum phosphate level.Keywords
This publication has 27 references indexed in Scilit:
- Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virusJournal of Viral Hepatitis, 2010
- A Case of Osteomalacia Related to Adefovir in a Patient with Chronic Hepatitis BThe Korean Journal of Gastroenterology, 2010
- Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxilWorld Journal of Hepatology, 2010
- Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil #Hepatology, 2009
- Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patientAIDS, 2009
- Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis BHepatology, 2008
- A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virusThe Korean Journal of Hepatology, 2008
- Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsGastroenterology, 2006
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis BNew England Journal of Medicine, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis BNew England Journal of Medicine, 2003